Evaluation of The Prognostic Values with Neutrophil-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease
Manimekalai P, Suresh Kanna S, Vijaykumar Edward and Anandan P
Journal of Angiotherapy 5(2) https://doi.org/10.25163/angiotherapy.52121692921211221
Submitted: 29 November 2021 Revised: 11 December 2021 Published: 21 December 2021
Abstract
Aging is an important risk factor for most chronic diseases. Patients with COPD develop more comorbidities than non-COPD subjects. We hypothesized that the development of comorbidities characteristically affecting the elderly occur at an earlier age in subjects with the diagnosis of COPD.
Keywords: chronic diseases, pulmonary disease, exacerbation
References
Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep 2012;61:1-51.
Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006;27:822-32.
https://doi.org/10.1183/09031936.06.00145104
Thomsen M, Ingebrigtsen TS, Marott JL, et al. In?ammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013;309:2353-61.
https://doi.org/10.1001/jama.2013.5732
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD executive summary. Am J Respir Crit Care Med 2017;195:557-82.
https://doi.org/10.1164/rccm.201701-0218PP
View Dimensions
View Altmetric
Save
Citation
View
Share